Sarcoma Clinical Trials and Research
- Targeted therapies for gastrointestinal stromal tumors (GIST) with tyrosine kinase inhibitors are an important focus. Newer drugs for GIST are currently being studied.
- Clinical trials of anti-angiogenesis agents, which prevent delivery of blood to tumors, and hypoxia-activating agents, which starve tumors of oxygen, are available for several subtypes of sarcoma.
- Both of these discuss soft tissue sarcomas
Learn more about Sarcoma clinical trials.
Trial Administration